| | 57852-57-0 Basic information More.. |
| Product Name: | Idarubicin hydrochloride | | Synonyms: | IDARUBICIN HYDROCHLORIDE;4-demethoxy-daunomycihydrochloride;4-demethoxydaunorubicinhydrochloride;(7s-cis)-9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-l-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione;4-DMD HCl;5,12-Naphthacenedione, 9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, hydrochloride, (7S,9S)-;Idarubicin hydrochloride, >=98%;DMDR, Idamycin, IMI-30, (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione | | CAS: | 57852-57-0 | | MF: | C26H28ClNO9 | | MW: | 533.95 | | EINECS: | 260-990-7 | | Mol File: | 57852-57-0.mol |  |
Use
Idarubicin hydrochloride is a derivative of daunorubicin indicated for acute nonlymphocytic
leukemia, acute lymphocytic leukemia, and acute myeloid leukemia.
Compared with daunorubicin, idarubicin hydrochloride is less cardiotoxic, has milder
side effects, is orally active and more potent in experimental leukemias. Idarubicin
hydrochloride is also reportedly active in daunorubicin-resistant patients, breast cancer,Hodgkin's and non-Hodgkin's lymphoma.
- Idarubicin Hydrochloride
-
- US $0.00 / KG
- 2024-03-12
- CAS:57852-57-0
- Min. Order: 1KG
- Purity: 98% HPLC
- Supply Ability: 5000kgs
- Idarubicin hydrochloride
-
- US $9.90-7.70 / g
- 2022-02-23
- CAS:57852-57-0
- Min. Order: 10g
- Purity: 99.99%HPLC.USP42
- Supply Ability: 1000kgs
|
|
57852-57-0
Recommend Suppliers |
|